Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OncoSec Medical Inc ONCSQ

Healthcare Biotechnology
OncoSec Medical Incorporated is a late-stage immuno-oncology company. The Company is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its core technology, ImmunoPulse, is a drug-device therapeutic modality platform comprised of an OncoSec... see more

Recent & Breaking News (GREY:ONCSQ)

OncoSec's Punit Dhillon Named "Most Admired CEO" by San Diego Business Journal

PR Newswire February 19, 2016

OncoSec to Host Second Quarter Financial Results Conference Call on March 8, 2016

PR Newswire February 18, 2016

OncoSec to Present at Prominent Investment Conferences in February

PR Newswire February 3, 2016

Immunotherapy Inside the Cell Interview by The Life Sciences Report

Marketwired January 8, 2016

OncoSec to Present at Prominent Investment Conferences in January

PR Newswire January 6, 2016

OncoSec Opens New Headquarters and Research Facility in San Diego

PR Newswire December 17, 2015

OncoSec Announces First Quarter Results for Fiscal Year End 2016

PR Newswire December 8, 2015

OncoSec to Host First Quarter Financial Results Conference Call on December 8, 2015

PR Newswire November 19, 2015

OncoSec Medical Closes $7.5 Million Registered Direct Offering

PR Newswire November 9, 2015

OncoSec Announces $7.5 Million Registered Direct Offering

PR Newswire November 3, 2015

OncoSec Enrolls First Patient in Biomarker-Focused Pilot Study in Triple Negative Breast Cancer

PR Newswire October 29, 2015

OncoSec Issues Annual Letter To Shareholders

PR Newswire October 27, 2015

OncoSec Announces Fourth Quarter and YTD Results for Fiscal Year End 2015

PR Newswire October 14, 2015

OncoSec to Present at Investment Conferences in October

PR Newswire October 5, 2015

OncoSec to Host Fourth Quarter Financial Results Conference Call and Live Webcast on October 15, 2015

PR Newswire October 1, 2015

OncoSec Announces Positive Results from Phase II Trial of ImmunoPulse(TM) IL-12 in Merkel Cell Carcinoma

PR Newswire September 27, 2015

OncoSec Appoints David P. Meininger, PhD, MBA, as Senior Vice President of Business Development

PR Newswire September 14, 2015

OncoSec Presents Advancements in Intratumoral Gene Electro-Transfer Devices for Immuno-Oncology

PR Newswire September 9, 2015

OncoSec to Present at Scientific and Investment Conferences in September

PR Newswire September 2, 2015

The NASDAQ Biotech Index Is Partying Like It's 1999 - Some Say The Party's Just Getting Started, Some Say We're At The Top

Accesswire August 24, 2015